A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Intervention Study

Results suggest the feasibility, acceptability, and preliminary efficacy of the VLC intervention in adults with higher genetic risk for metabolic dysfunction-associated steatotic liver disease, although there is a need for further studies given the small sample size and the high risk of substantial biases in this small pilot study.

Authors

Institutions

Publication Details

Journal
JMIR Formative Research
Published
2025-01-10
DOI
https://doi.org/10.2196/60051
Citations
3
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
4.06
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Intervention Study

Elizabeth K. Speliotes, Laura R. Saslow, Dina Mohamed Hafez, Alison O’Brien et al.
3 citations
JMIR Formative Research
Liver Disease Diagnosis and Treatment
4.06
article

A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Intervention Study

Elizabeth K. Speliotes, Laura R. Saslow, Dina Mohamed Hafez, Alison O’Brien, Hovig Bayandorian, Judith T. Moskowitz, Jamie Krinock, Jennifer Daubenmier, Deanna J. Marriott, Kaitlyn Raymond, Antonino Oliveri
article en
3 citations

Abstract

Results suggest the feasibility, acceptability, and preliminary efficacy of the VLC intervention in adults with higher genetic risk for metabolic dysfunction-associated steatotic liver disease, although there is a need for further studies given the small sample size and the high risk of substantial biases in this small pilot study.

JMIR Formative ResearchVol. 9
Northwestern University (US), University of Michigan (US), VA Ann Arbor Healthcare System (US), San Francisco State University (US)
Openalex Percentile: Top 8%
Liver Disease Diagnosis and Treatment
4.06
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

A Very Low–Carbohydrate Program in Adults With Metabolic Dysfunction–Associated Steatotic Liver Disease and Phospholipase Domain–Containing Protein 3 Risk Genotype: Pre-Post Intervention Study — Elizabeth K. Speliotes, Laura R. Saslow, et al. · JMIR Formative Research (2025) | TGRS Research Map | TGRS